Shenzhen Chipscreen Biosciences Co., Ltd.
SHH: 688321.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Xian-Ping Lu
- Employees
- 1,057
- Headquarters
- Shenzhen, China
- IPO year
- 2019
- Market cap
- CN¥13.9B
- Website
- https://www.chipscreen.com
Loading 688321…
Loading profile data…Frequently asked questions about 688321
What does Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS) do?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and...
Where does 688321.SS trade?
Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS) trades on the Shanghai Stock Exchange.
What sector is 688321.SS in?
Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shenzhen Chipscreen Biosciences Co., Ltd.?
Xian-Ping Lu is the chief executive officer of Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS).
Where is Shenzhen Chipscreen Biosciences Co., Ltd. headquartered?
Shenzhen Chipscreen Biosciences Co., Ltd. is headquartered in China.
Does 688321.SS pay a dividend?
Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 688321.SS go public?
Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS) completed its initial public offering in 2019.